91 related articles for article (PubMed ID: 16720350)
1. Changes in gene expression with increased transglutaminase 2 in a SH-SY5Y cell line.
Lee JS; Kim IH; Kim SY
Front Biosci; 2006 Sep; 11():2774-81. PubMed ID: 16720350
[TBL] [Abstract][Full Text] [Related]
2. A new regulatory mechanism of NF-kappaB activation by I-kappaBbeta in cancer cells.
Kim JM; Voll RE; Ko C; Kim DS; Park KS; Kim SY
J Mol Biol; 2008 Dec; 384(4):756-65. PubMed ID: 18950638
[TBL] [Abstract][Full Text] [Related]
3. TNF-alpha mediated NF-kappaB activation is constantly extended by transglutaminase 2.
Park KS; Kim DS; Ko C; Lee SJ; Oh SH; Kim SY
Front Biosci (Elite Ed); 2011 Jan; 3(1):341-54. PubMed ID: 21196314
[TBL] [Abstract][Full Text] [Related]
4. Reversal of drug resistance in breast cancer cells by transglutaminase 2 inhibition and nuclear factor-kappaB inactivation.
Kim DS; Park SS; Nam BH; Kim IH; Kim SY
Cancer Res; 2006 Nov; 66(22):10936-43. PubMed ID: 17108131
[TBL] [Abstract][Full Text] [Related]
5. Retinoic acid receptors and tissue-transglutaminase mediate short-term effect of retinoic acid on migration and invasion of neuroblastoma SH-SY5Y cells.
Joshi S; Guleria R; Pan J; DiPette D; Singh US
Oncogene; 2006 Jan; 25(2):240-7. PubMed ID: 16158052
[TBL] [Abstract][Full Text] [Related]
6. I-kappaBalpha depletion by transglutaminase 2 and mu-calpain occurs in parallel with the ubiquitin-proteasome pathway.
Kim DS; Han BG; Park KS; Lee BI; Kim SY; Bae CD
Biochem Biophys Res Commun; 2010 Aug; 399(2):300-6. PubMed ID: 20659425
[TBL] [Abstract][Full Text] [Related]
7. Tissue transglutaminase differentially modulates apoptosis in a stimuli-dependent manner.
Tucholski J; Johnson GV
J Neurochem; 2002 May; 81(4):780-91. PubMed ID: 12065637
[TBL] [Abstract][Full Text] [Related]
8. Homocysteine-induced toxicity increases TG2 expression in Neuro2a cells.
Currò M; Condello S; Caccamo D; Ferlazzo N; Parisi G; Ientile R
Amino Acids; 2009 Apr; 36(4):725-30. PubMed ID: 18594946
[TBL] [Abstract][Full Text] [Related]
9. Tissue transglutaminase is essential for neurite outgrowth in human neuroblastoma SH-SY5Y cells.
Tucholski J; Lesort M; Johnson GV
Neuroscience; 2001; 102(2):481-91. PubMed ID: 11166134
[TBL] [Abstract][Full Text] [Related]
10. Increased tissue transglutaminase expression in human atherosclerotic coronary arteries.
Cho BR; Kim MK; Suh DH; Hahn JH; Lee BG; Choi YC; Kwon TJ; Kim SY; Kim DJ
Coron Artery Dis; 2008 Nov; 19(7):459-68. PubMed ID: 18923241
[TBL] [Abstract][Full Text] [Related]
11. Depletion of cathepsin D by transglutaminase 2 through protein cross-linking promotes cell survival.
Kim SJ; Kim KH; Ahn ER; Yoo BC; Kim SY
Amino Acids; 2013 Jan; 44(1):73-80. PubMed ID: 21960143
[TBL] [Abstract][Full Text] [Related]
12. The mechanism of transglutaminase 2 inhibition with glucosamine: implications of a possible anti-inflammatory effect through transglutaminase inhibition.
Jeong KC; Ahn KO; Lee BI; Lee CH; Kim SY
J Cancer Res Clin Oncol; 2010 Jan; 136(1):143-50. PubMed ID: 19655169
[TBL] [Abstract][Full Text] [Related]
13. Transglutaminase II interacts with rac1, regulates production of reactive oxygen species, expression of snail, secretion of Th2 cytokines and mediates in vitro and in vivo allergic inflammation.
Kim Y; Eom S; Kim K; Lee YS; Choe J; Hahn JH; Lee H; Kim YM; Ha KS; Ro JY; Jeoung D
Mol Immunol; 2010 Feb; 47(5):1010-22. PubMed ID: 20004474
[TBL] [Abstract][Full Text] [Related]
14. Transglutaminase 2 mediates polymer formation of I-kappaBalpha through C-terminal glutamine cluster.
Park SS; Kim JM; Kim DS; Kim IH; Kim SY
J Biol Chem; 2006 Nov; 281(46):34965-72. PubMed ID: 16987813
[TBL] [Abstract][Full Text] [Related]
15. Transglutaminase 2 and NF-kappaB interplay during NGF-induced differentiation of neuroblastoma cells.
Condello S; Caccamo D; Currò M; Ferlazzo N; Parisi G; Ientile R
Brain Res; 2008 May; 1207():1-8. PubMed ID: 18374307
[TBL] [Abstract][Full Text] [Related]
16. Glucosamine is an effective chemo-sensitizer via transglutaminase 2 inhibition.
Kim DS; Park KS; Jeong KC; Lee BI; Lee CH; Kim SY
Cancer Lett; 2009 Jan; 273(2):243-9. PubMed ID: 18804908
[TBL] [Abstract][Full Text] [Related]
17. Transglutaminase-2 Is Involved in All-Trans Retinoic Acid-Induced Invasion and Matrix Metalloproteinases Expression of SH-SY5Y Neuroblastoma Cells via NF-κB Pathway.
Lee HJ; Park MK; Bae HC; Yoon HJ; Kim SY; Lee CH
Biomol Ther (Seoul); 2012 May; 20(3):286-92. PubMed ID: 24130925
[TBL] [Abstract][Full Text] [Related]
18. Novel suppressive effects of cardamonin on the activity and expression of transglutaminase-2 lead to blocking the migration and invasion of cancer cells.
Park MK; Jo SH; Lee HJ; Kang JH; Kim YR; Kim HJ; Lee EJ; Koh JY; Ahn KO; Jung KC; Oh SH; Kim SY; Lee CH
Life Sci; 2013 Feb; 92(2):154-60. PubMed ID: 23201552
[TBL] [Abstract][Full Text] [Related]
19. Cell type-specific activation of intracellular transglutaminase 2 by oxidative stress or ultraviolet irradiation: implications of transglutaminase 2 in age-related cataractogenesis.
Shin DM; Jeon JH; Kim CW; Cho SY; Kwon JC; Lee HJ; Choi KH; Park SC; Kim IG
J Biol Chem; 2004 Apr; 279(15):15032-9. PubMed ID: 14752105
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of transglutaminase 2 drives glycolytic metabolism in renal carcinoma cells.
Ku BM; Lee CH; Lee SH; Kim SY
Amino Acids; 2014 Jun; 46(6):1527-36. PubMed ID: 24643363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
